Related Experiment Video

Updated: May 28, 2026

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Congenital myotonic dystrophy in a national registry

Patrick Prendergast1, Sandra Magalhaes, Craig Campbell

  • 1William Singeris National Centre for Myotonic Dystrophy Research;

Paediatrics & Child Health
|October 4, 2011
PubMed

Insights

Congenital myotonic dystrophy (CDM) patients in a US registry show common gastrointestinal, pneumonia, and cardiac issues. This registry is valuable for research, though it has limitations compared to other programs.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Congenital myotonic dystrophy (CDM) is a severe form of myotonic dystrophy.
  • Understanding its neonatal symptoms and long-term morbidities is crucial for patient care and research.
  • The United States National Registry of Myotonic Dystrophy provides a platform for disease-specific, self-reported data.

Purpose of the Study:

  • To characterize the neonatal presentation, developmental challenges, and chronic multisystem medical conditions in patients with CDM.
  • To leverage data from the United States National Registry of Myotonic Dystrophy for clinical research.
  • To compare findings with the Canadian Paediatric Surveillance Program for CDM.

Main Methods:

  • Analysis of genetically confirmed CDM cases with symptoms appearing within the first four weeks of life.
  • Utilizing survey data collected at baseline and annually from patients (or caregivers) and physicians.
  • Inclusion of 21 patients (13 male, 8 female) aged 3-24 years with CTG trinucleotide repeat numbers from 940 to 2100.

Main Results:

  • Gastrointestinal issues, pneumonia, and cardiac morbidities were the most frequently observed medical problems.
  • No patient deaths were reported during the study period.
  • The registry captured a range of ages and genetic repeat expansions characteristic of CDM.

Conclusions:

  • The United States National Registry of Myotonic Dystrophy serves as a significant resource for advancing clinical research in CDM.
  • The registry's self-report nature and data collection methods present certain limitations when compared to programs like the Canadian Paediatric Surveillance Program.
  • Further research utilizing registry data can improve understanding and management of CDM.
Abstract

Keywords:
Congenital myotonic dystrophyNeonatalPaediatricRegistryTrinucleotide repeat disorder

More Related Videos

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

Related Concept Videos

Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...